Aquestive Therapeutics Inc. has announced the promotion of Sherry Korczynski to the position of Chief Commercial Officer, effective July 22, 2025. Previously serving as Senior Vice President of Sales and Marketing, Korczynski joined the company in February 2024. She brings over two decades of experience in commercial and launch roles at various pharmaceutical companies, including leading efforts for EpiPen. In her new role, she will oversee the global commercial strategy for Anaphylm, an innovative orally delivered epinephrine product.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.